Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-05-25
1997-07-08
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142328, 514 80, 544115, 544337, 544344, A61K 31495, A61K 31675, C07D24138, C07F 96509
Patent
active
056461461
ABSTRACT:
The present invention relates to 9H-indeno[1,2-b]pyrazin-3(4H)-ones and 9H-indeno[1,2-b]pyrazine-2,3(1H,4H)-diones or tautomeric forms thereof which are useful in treating neurological and psychiatric diseases based on the antagonism of the glycine binding site on the NMDA receptor complex.
REFERENCES:
patent: 4889855 (1989-12-01), Jacobsen et al.
patent: 4912108 (1990-03-01), Jacobsen et al.
patent: 5026704 (1991-06-01), Honore et al.
patent: 5081123 (1992-01-01), Honore et al.
patent: 5153195 (1992-10-01), Honore et al.
patent: 5182279 (1993-01-01), Jorgensen et al.
Bergel et al, "Journal of Chemical Society", 1964, University College, (London), pp. 3973-3981.
A.W. Johnson et al, "Journal of Chemical Society", 1960, University College, (London), pp. 3412-3413.
Faarup Peter
J.o slashed.rgensen Anker Steen
Jakobsen Palle
Klitgaard Henrik
Bernhardt Emily
Lambiris, Esq. Elias J.
Novo Nordisk A S
Zelson Esq. Steve T.
LandOfFree
Heterocyclic compounds and their preparation and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compounds and their preparation and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds and their preparation and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2408972